Skip to main content
. Author manuscript; available in PMC: 2017 Aug 3.
Published in final edited form as: Am J Transplant. 2016 Jan;16(Suppl 2):11–46. doi: 10.1111/ajt.13666

Figure KI 5.8. Incidence of PTLD among adult kidney transplant recipients, by recipient EBV status at transplant, 2008–2012.

Figure KI 5.8

Cumulative incidence is estimated using the Kaplan-Meier competing risk method. PTLD is identified as a reported complication or cause of death on the OPTN Transplant Recipient Follow-up Form or the Posttransplant Malignancy Form as polymorphic PTLD, monomorphic PTLD, or Hodgkin disease. Only the earliest date of PTLD diagnosis is considered. EBV, Epstein-Barr virus; PTLD, posttransplant lymphoproliferative disorder.